Growth without growth hormone receptor:: Estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis

被引:56
|
作者
Venken, K
Schuit, F
Van Lommel, L
Tsukamoto, K
Kopchick, JJ
Coschigano, K
Ohlsson, C
Movérare, S
Boonen, S
Bouillon, R
Vanderschueren, D
机构
[1] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Div Biochem, Gene Express Unit, B-3000 Louvain, Belgium
[3] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA
[4] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA
[5] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Ctr Bone Res, Gothenburg, Sweden
[6] Katholieke Univ Leuven, Univ Louvain, Ctr Metab Bone Dis, Louvain, Belgium
[7] Katholieke Univ Leuven, Div Geriatr Med, Louvain, Belgium
关键词
growth hormone receptor knockout mouse; bone; estrogens; IGF-I; liver gene expression;
D O I
10.1359/JBMR.050811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of estrogens in the regulation of pubertal growth independently of GH and its receptor was studied in male mice with disrupted GHRKO. E-2 rescued skeletal growth rates in GHRKO associated with an increase in hepatic and serum IGF-I. These data show that E-2 rescues pubertal growth during GH resistance through a novel mechanism of GHR-independent stimulation of hepatic IGF-I production. Introduction: Growth hormone (GH) and estrogen play a pivotal role in pubertal growth and bone mineral acquisition. Estrogens can affect GH secretion and thereby provide a GH-dependent mechanism for their effects on skeletal growth. It is presently unclear if or to what extent estrogens are able to regulate pubertal growth and bone mineral accrual independently of GH and its receptor. Materials and Methods: Estradiol (E-2; 0.03 mu g/day by subcutaneous silastic implants) was administered to orchidectomized (ORX) male mice with disrupted GHR (GHRKO) and corresponding WTs during late puberty (6-10 weeks). Longitudinal and radial bone growth, IGF-I in serum and its expression in liver, muscle, and bone, and liver gene expression were studied by histomorphometry, RIA, RT-PCR, microarrays, and Western blotting, respectively. Results: E-2 stimulated not only longitudinal (femur length and growth plate thickness) and radial growth (cortical thickness and periosteal perimeter), but also rescued longitudinal and periosteal growth rates in ORX GHRKO, whereas no significant changes occurred in WT. E-2 thereby upregulated serum IGF-I and liver IGF-I synthesis (+21% and +52%, respectively) in ORX GHRKO, whereas IGF-I synthesis in femur or muscle was unaffected. Study of the underlying mechanism of the stimulation of hepatic IGF-I expression showed that E-2 restored downregulated receptor signaling systems, such as the estrogen receptor alpha and the prolactin receptor. E-2 thereby recovered the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway as evidenced by a significantly increased activation of the transcription factor STAT5 in ORX GHRKO. Conclusions: Our data show a stimulation of skeletal growth through upregulation of hepatic IGF-I by a hormone other than GH. E-2 rescues pubertal skeletal growth during GH resistance through a novel mechanism of GHR-independent stimulation of IGF-I synthesis in the liver.
引用
收藏
页码:2138 / 2149
页数:12
相关论文
共 50 条
  • [41] Growth hormone receptor signaling and differential actions in target tissues compared to IGF-I
    Kelly, PA
    Bachelot, A
    Sotiropoulos, A
    Binart, N
    Deciphering Growth, 2005, : 65 - 75
  • [42] Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans
    Jaffe, CA
    Turgeon, DK
    Lown, K
    Demott-Friberg, R
    Watkins, PB
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (05): : E1008 - E1015
  • [43] GROWTH-HORMONE AND PROLACTIN STIMULATE ANDROGEN RECEPTOR, INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND IGF-I RECEPTOR LEVELS IN THE PROSTATE OF IMMATURE RATS
    REITER, E
    BONNET, P
    SENTE, B
    DOMBROWICZ, D
    DELEVAL, J
    CLOSSET, J
    HENNEN, G
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1992, 88 (1-3) : 77 - 87
  • [44] Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia
    David L. Kleinberg
    Pietro Ameri
    Baljit Singh
    Pituitary, 2011, 14 : 44 - 52
  • [45] Effects of growth hormone at breeding on the offspring's insulin-like growth factor-I (IGF-I) response to growth hormone releasing hormone challenge.
    Koch, J. M.
    Lemley, C. O.
    Wilson, M. E.
    JOURNAL OF ANIMAL SCIENCE, 2007, 85 : 138 - 139
  • [46] Growth hormone-independent cardioprotective effects of hexarelin in the rat
    Locatelli, V
    Rossoni, G
    Schweiger, F
    Torsello, A
    Colonna, VD
    Bernareggi, M
    Deghenghi, R
    Müller, EE
    Berti, F
    ENDOCRINOLOGY, 1999, 140 (09) : 4024 - 4031
  • [47] Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia
    Kleinberg, David L.
    Ameri, Pietro
    Singh, Baljit
    PITUITARY, 2011, 14 (01) : 44 - 52
  • [48] EFFECTS OF GROWTH-HORMONE AND AN ANTISERUM TO RAT GROWTH-HORMONE ON SERUM IGF-I AND MUSCLE PROTEIN-SYNTHESIS AND ACCRETION IN THE RAT
    PALMER, RM
    FLINT, DJ
    MACRAE, JC
    FAIRHURST, FE
    BRUCE, LA
    MACKIE, SC
    LOBLEY, GE
    JOURNAL OF ENDOCRINOLOGY, 1993, 139 (03) : 395 - 401
  • [49] Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5
    Sims, NA
    Clément-Lacroix, P
    Da Ponte, F
    Bouali, Y
    Binart, N
    Moriggl, R
    Goffin, V
    Coschigano, K
    Gaillard-Kelly, M
    Kopchick, J
    Baron, R
    Kelly, PA
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (09): : 1095 - 1103
  • [50] REGULATION BY GROWTH-HORMONE OF NUMBER OF CHONDROCYTES CONTAINING IGF-I IN RAT GROWTH PLATE
    NILSSON, A
    ISGAARD, J
    LINDAHL, A
    DAHLSTROM, A
    SKOTTNER, A
    ISAKSSON, OGP
    SCIENCE, 1986, 233 (4763) : 571 - 574